Treatment of depressed methadone maintenance patients with nefazodone: A case series

American Journal on Addictions

Volumn 7, Issue 4, 1998, Pages 309-312

  Hamilton, Steven P ^a   Klimchak, Carol ^b   Nunes, Edward V ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; METHADONE; NEFAZODONE; RISPERIDONE; SERTRALINE;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; DISEASE ASSOCIATION; HUMAN; MALE; OPIATE ADDICTION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0031794266     PISSN: 10550496     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1521-0391.1998.tb00351.x     Document Type: Article

References (12)

1. Rounsaville BJ, Weissman MM, Crits-Christoph K, et al: Diagnosis and symptoms of depression in opiate addicts. Arch Gen Psychiatry 1982; 39:151-156
2. Rounsaville BJ, Kosten TR, Weissman MM, et al: Prognostic significance of psychopathology in treated opiate addicts. Arch Gen Psychiatry 1986; 43:739-745
3. Nunes EV, Quitkin FM, Donovan SJ, et al: Imipramine treatment of opiate-dependent patients with depressive disorders. Arch Gen Psychiatry 1998; 55:153-160
4. Woody GE, O'Brien BA, Rickels K: Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone. Am J Psychiatry 1975; 132:447-450
5. Petrakis I, Carroll K, Gordon L, et al: Fluoxetine treatment for dually diagnosed methadone maintained opioid addicts: a pilot study. J Addict Dis 1994; 13:25-32
6. Feiger A, Kiev A, Shrivastava RK, et al: Nefazodone vs. sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996; 57(suppl 2):53-62
7. Armitage R, Yonkers K, Cole D, et al: A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients. J Clin Psychopharmacol 1997; 17:161-168
8. Sharpley AL, Walsh AES, Cowen PJ: Nefazodone, a novel antidepressant, may increase REM sleep. Biol Psychiatry 1992; 31:1070-1073
9. Gillin JC, Rapaport M, Erman MK, et al: A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial. J Clin Psychiatry 1997; 58:185-192
10. Iribarne C, Berthou F, Baird S, et al: Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Chem Res Toxicol 1996; 9:365-373
11. Richelson E: Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs. Mayo Clin Proc 1997; 72:835-847
12. Stewart JW, McGrath PJ, Quitkin FM, et al: Relevance of DSM-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Arch Gen Psychiatry 1989; 46:1080-1087